[Chavanprash in the treatment of hyperplastic processes in the endometrium].

Hyperplastic processes in the endometrium are classified as a common gynecological pathology. The drug chavanprash has been shown to improve general bodily resistance, to enhance vital tone of the body. It is endowed with a manifest hepatotropic and antitoxic activity, which fact permits recommending it for use in the combination therapy of hyperplastic processes in the endometrium as well as during the period of rehabilitation in the wake of the course of hormonotherapy.

[Changes in the neuroendocrine and immune state of adaptational homeostasis in normal pregnancy].

43 women with physiologically proceeding pregnancy have been examined during 1st, 2nd and 3d terms. The control group consists of 28 practically healthy non-pregnant women. It is stated that during pregnancy essential changes in the function of endocrine glands of mother take place.

[Experience in the use of vaginal and intracervical enzaprost suppositories in preparation for labor].

To improve the efficacy of prelabor treatment of pregnant women with some obstetrical abnormalities, such as over-term pregnancy, AB0- and Rh-isosensitization, anemia, gestosis of the second half of pregnancy, vaginal and intracervical suppositories containing 0.1 mg of enzaprost were administered to 102 women for 1-5 days. In 30 (29.

[Status of the endocrine function of the thymus gland in the normal and complicated course of pregnancy].

A total of 84 women with normal pregnancy and those with threatened abortions were examined, as were 28 healthy nonpregnant women, to estimate the function of the thymus. The findings evidence enhancement of the endocrine function of the thymus in pregnancy, this function being assessed from the thymic serum factor titer. The function activation is related to pregnancy course and is more marked in threatened abortion.

[Effect of umbilical cord pathology on the outcome of labor].

Literature and the authors' evidence concerning effects of umbilical abnormality on maternal and fetal outcomes has been overviewed. It is emphasized that identification of umbilical abnormality during labor and delivery, but not only during pregnancy, will improve obstetric outcomes.